Long-term effect of α-glucosidase inhibitor on late dumping syndrome

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 12, 1998, Pages 1201-1206

  Hasegawa, Takenao ^a,b,c   Yoneda, Masashi ^a,d   Nakamura, Kimihide ^a   Ohnishi, Kuniyo ^a,c   Harada, Hiroyuki ^c   Kyouda, Takeshi ^c   Yoshida, Yoshikazu ^c   Makino, Isao ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b Department of Gastroenterology   (Japan)

^c National Hospital Organization   (Japan)

^d INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Dumping syndrome; Reactive hypoglycaemia; glucosidase inhibitor

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; GLUCAGON; GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FLATULENCE; GASTRECTOMY BILLROTH II; GLUCOSE BLOOD LEVEL; HEART PALPITATION; HUMAN; INSULIN RELEASE; MALE; MUSCLE WEAKNESS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; POSTGASTRECTOMY SYNDROME; POSTOPERATIVE COMPLICATION; POSTPRANDIAL STATE; PRIORITY JOURNAL; STOMACH CARCINOMA; STOMACH ULCER; VERTIGO;

EID: 0032443006     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1998.01783.x     Document Type: Article

References (33)

1. Debase H, Orloff S. Surgery for peptic ulcer disease. In: Yamada T, eds. Textbook of Gastroenterology (Vol. 1). Philadelphia: JB Lippincott Company, 1991; 1379-98.
2. Bloom SR, Royston CM, Thomson JP. Enteroglucagon release in the dumping syndrome. Lancet 1972; ii: 789-91.
3. Blackburn AM, Lawaetz O, Bloom SR. Plasma neurotensin release and gastric emptying in the dumping syndrome. Life Sci. 1983; 32: 833-7.
4. Shultz KT, Neelon FA, Nilsen LB, Lebovitz HE. Mechanism of postgastrectomy hypoglycemia. Arch. Intern. Med. 1971; 128: 240-6.
5. Wapnick S, Jones JJ. Changes in glucose tolerance and serum insulin following partial gastrectomy and intestinal resection. Gut 1972; 13: 871-3.
6. Rivkees SA, Crawford JD. Hypoglycemia pathogenesis in children with dumping syndrome. Pediatrics 1987; 80: 937-42.
7. Harju E, Nordback I. Postprandial hyperglycemia after different carbohydrates in patients with total gastrectomy. Surg. Gynecol. Obstet. 1987; 165: 41-5.
8. Jenkins DJ, Gassull MA, Leeds AR et al. Effect of dietary fiber on complications of gastric surgery: Prevention of postprandial hypoglycemia by pectin. Gastroenterology 1977; 73: 215-17.
9. Jenkins DJ, Taylor RH, Nineham R et al. Combined use of guar and acarbose in reduction of postprandial glycaemia. Lancet 1979; ii: 924-7.
10. Geer RJ, Richards WO, O'Dorisio TM et al. Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome. Ann. Surg. 1990; 212: 678-87.
11. Fink WJ, Hucke ST, Gray TW, Thompson BW, Read RC. Treatment of postoperative reactive hypoglycemia by a reversed intestinal segment. Am. J. Surg. 1976; 131: 19-22.
12. Hasler WL, Soudah HC, Owyang C. Mechanisms by which octreotide ameliorates symptoms in the dumping syndrome. J. Pharmacol. Exp. Ther. 1996; 277: 1359-65.
13. Bischoff H. Pharmacology of α-glucosidase inhibition. Eur. J. Clin. Invest. 1994; 3: 3-10.
14. Hillebrand I, Boehme K, Frank G, Fink H, Berchtold P. The effect of the α-glucosidase inhibitor BAYg5421 (acarbose) on meal-stimulated elevations of circulating glucose, insulin and triglyceride levels in man. Res. Exp. Med. 1979; 175: 81-6.
15. Goke B, Herrmann C, Goke R et al. Intestinal effects of α-glucosidase inhibitors: Absorption of nutrients and enterohormonal changes. Eur. J. Clin. Invest. 1994; 3: 25-30.
16. Spengler M, Cagatay M. The use of acarbose in the primary-care setting: Evaluation of efficacy and tolerability of acarbose by postmarketing surveillance study. Clin. Invest. Med. 1995; 18: 325-31.
17. Toeller M. α-Glucosidase inhibitors in diabetes: Efficacy in NIDDM subjects. Eur. J. Clin. Invest. 1994; 3: 31-5.
18. Hoffmann J, Spengler M. Efficacy of 24-week monotherapy with acarbose, glibenclamide or placebo in NIDDM patients. The Essen Study. Diabetes Care 1994; 17: 561-6.
19. Peterson RG. α-Glucosidase inhibitors in diabetes: Lessons from animal studies. Eur. J. Clin. Invest. 1994; 3: 11-18.
20. Lefebvre PJ, Scheen AJ. The use of acarbose in the prevention and treatment of hypoglycaemia. Eur. J. Clin. Invest. 1994; 3: 40-4.
21. McLoughlin JC, Buchanan KD, Alam MJ. A glycosidehydrolase inhibitor in treatment of dumping syndrome. Lancet 1979; ii: 603-5.
22. Sawyers J. Management of postgastrectomy syndromes. Am. J. Surg. 1990; 159: 8-14.
23. Ralphs DN, Thomson JP, Haynes S, Lawson SC, Hobsley M, Le QL. The relationship between the rate of gastric emptying and the dumping syndrome. Br. J. Surg. 1978; 65: 637-41.
24. Truscheit E, Hillebrand I, Jung B, Muller L, Pulus W, Schmidt D. Microbial α-glucosidase inhibitors: Chemistry, biochemistry and therapeutic potential. Prog. Biochem. Med. 1988; 7: 17-99.
25. Gerard J, Luyckx AS, Lefebvre PJ. Acarbose in reactive hypoglycemia: A double-blind study. Int. J. Clin. Pharmacol. Ther. Toxicol. 1984; 22: 25-31.
26. Renard E, Parer RC, Richard JL, Jureidini S, Orsetti A, Mirouze J. Effect of Miglitol (Bay m1099), a new alpha-glucosidase inhibitor, on glucose, insulin, C-peptide and GIP responses to an oral sucrose load in patients with post-prandial hypoglycaemic symptoms. Diabetes Metab. 1991; 17: 355-62.
27. Speth P, Jansen J, Lamers C. Effect of acarbose, peptin, a combination of acarbose with pectin, and placebo on postprandial reactive hypoglycemia after gastric surgery. Gut 1983; 24: 798-802.
28. Palardy J, Havrankova J, Lepage R, Matte R, Belanger R, D'Amour P. Blood glucose measurements during symptomatic episodes in patients with suspected postprandial hypoglycemia. N. Engl. J. Med. 1989; 321: 1421-5.
29. Hadji GA, Schmidt MI, Margolis S, Kowarski AA. Elevated hypoglycemic index and late hyperinsulinism in symptomatic postprandial hypoglycemia. J. Clin. Endocrinol. Metab. 1980; 50: 371-6.
30. Gulsrud PO, Taylor IL, Watts HD, Cohen MB, Elashoff J, Meyer JH. How gastric emptying of carbohydrate affects glucose tolerance and symptoms after truncal vagotomy with pyloroplasty. Gastroenterology 1980; 78: 1463-71.
31. Miholic J, Orskov C, Holst JJ, Kotzerke J, Meyer HJ. Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy. Dig. Dis. Sci. 1991; 36: 1361-70.
32. Qualmann C, Nauck MA, Holst JJ, Orskov C, Creutzfeldt W. Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose). Scand. J. Gastroenterol. 1995; 30: 892-6.
33. Sels JP, Kingma PJ, Wolffenbuttel BH, Menheere PP, Branolte JH, Nieuwenhuijzen KA. Effect of miglitol (BAY m1099) on fasting blood glucose in type 2 diabetes mellitus. Neth. J. Med. 1994; 44: 198-201.